-
Idiopathic Parkinson’s disease and Sensory disorders: A complication of dopatherpy or an intrinsic feature of the disease?
-
Idiopathic rhombencephalitis involving the substantia nigra followed by rapidly progressive parkinsonian syndrome in a young patient
-
iFall: Co-producing an instrumented application prototype for falls reporting in Parkinson’s disease
-
Immune-Mediated and Mercury Intoxication Ataxias: Anti-GAD Antibodies and Dynamic Stabilometriс Assessment
-
Immune-mediated movement disorder as a Rare Manifestation of a Sarcoma
-
IMMUNE-MEDIATED MOVEMENT DISORDERS: CLINICAL MANIFESTATIONS, TREATMENT, AND EVOLUTION. A MULTICENTER STUDY
-
Impact of 3-month earlier versus postponed initiation of opicapone versus entacapone in levodopa-treated patients with Parkinson’s disease and motor fluctuations
-
Impact of ALXN1840 on the neurological symptoms of Wilson disease: secondary outcomes of a phase 2, open-label, single-arm study
-
Impact of Covid-19 on Essential Tremor and Dystonic Tremor: experience of an Italian centre
-
Impact of COVID-19 pandemic on development of chronic stress syndromes in patients with Parkinson’s Disease : preliminary results
- « Previous Page
- 1
- …
- 60
- 61
- 62
- 63
- 64
- …
- 132
- Next Page »